Back to Search
JEFFREY DOME, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1902809197Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD036384(DC)
Research & Publications (20)
Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
PMID 18989885·Pediatr Blood Cancer·2009
8-other
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group.
PMID 19208794·Clin Cancer Res·2009
8-other
Retroperitoneal lymph node dissection for pediatric renal cell carcinoma.
PMID 19003909·Pediatr Blood Cancer·2009
8-other
Current and emerging chemotherapy treatment strategies for Wilms tumor in North America.
PMID 18345721·Paediatr Drugs·2008
6-review
Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
PMID 18704985·Cancer·2008
8-other
Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis.
PMID 17226850·Pediatr Blood Cancer·2008
8-other
Molecular characterization of the pediatric preclinical testing panel.
PMID 18628472·Clin Cancer Res·2008
7-preclinical
Pediatric Clinics of North America: pediatric oncology. Preface.
PMID 18242311·Pediatr Clin North Am·2008
8-other
Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
PMID 17369505·J Clin Pathol·2008
8-other
Wilms tumour: prognostic factors, staging, therapy and late effects.
PMID 18026723·Pediatr Radiol·2008
6-review
The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006.
PMID 18361398·Cancer·2008
8-other
Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.
PMID 17103382·J Pathol·2007
5-case
Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH.
PMID 17370329·Genes Chromosomes Cancer·2007
8-other
Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor.
PMID 17707428·J Urol·2007
8-other
ELR+-CXC chemokines and their receptors in early metanephric development.
PMID 17634442·J Am Soc Nephrol·2007
7-preclinical
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
PMID 17634492·J Clin Oncol·2007
3-trial
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis.
PMID 16799645·Oncogene·2006
8-other
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.
PMID 16446328·J Clin Oncol·2006
3-trial
Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
PMID 16772877·J Pediatr Hematol Oncol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 MICHIGAN AVE NW, DEPT OF HEMATOLOGY/ONCOLOGY
WASHINGTON, DC 20010 - Phone
- (202) 476-2800
Quick Facts
- NPI
- 1902809197
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile